Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Résultat
de votre recherche par promoteur : Gilead Sciences
Femme et Homme Max 99 ans
Gilead Sciences, Inc
MAJ Il y a 4 ans
A Study to Assess a New Treatment in Patients with Moderately to Severely Active Crohn’s Disease
The primary objectives of Cohort A Induction Study are: • To evaluate the efficacy of filgotinib as compared to placebo in establishing clinical remission by Patient Reported Outcomes (PRO2) at Week ...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme
Entre 18 ans
et 99 ans
Gilead Sciences
MAJ Il y a 4 ans
Etude GS-US-296-1080 : étude randomisée de phase 3 comparative visant à évaluer l’efficacité et la sécurité du GS-5745 associé au mFOLFOX6 en comparaison au mFOLFOX6 seul, en 1ère ligne de traitement chez des patients ayant un cancer gastrique avancé ou un adénocarcinome de la jonction gastro-oesophagienne. [essai clos aux inclusions]
L’adénocarcinome de l’estomac est le plus fréquent des cancers gastro-intestinaux dans le monde. L’adénocarcinome de la jonction gastro-oesophagienne est en rapide augmentation. Le traitement de 1ère ...
Pays
France
Organes
Estomac
Spécialités
Chimiothérapie
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Gilead Sciences, Inc
MAJ Il y a 4 ans
This trial will test the drug filgotinib for the treatment of fistulas around the anus (perianal) as a complication of Crohn’s disease. Este ensayo probará el fármaco filgotinib para el tratamiento de fístulas alrededor del ano (perianal) como una complicación de la enfermedad de Crohn
The primary objective of this study is to evaluate the efficacy of filgotinib as compared to placebo in establishing combined fistula response at Week 24 Evaluar la eficacia de filgotinib en com...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Gilead Sciences Ltd
MAJ Il y a 4 ans
CALiBRe: Assessment of the Mechanism of Action of idelalisib (CAL101) in B-cell Receptor Pathway Inhibition in CLL
http://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-looking-at-how-idelalisib-works-for-people-with-chronic-lymphocytic-leukaemia-calibre
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Gilead Sciences, Inc
MAJ Il y a 4 ans
A Clinical trial to evaluate safety, and effectiveness of GS-4997 in combination with an existing therapy (prednisolone) vs prednisolone alone in subjects with Severe Alcoholic Hepatitis
The primary objective of this study is as follows: To evaluate the safety and tolerability of GS-4997 in combination with prednisolone versus prednisolone alone in subjects with severe AH.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Gilead Sciences, Inc
MAJ Il y a 4 ans
A Clinical Trial to Evaluate the Effects of the drug Aztreonam Lysine for Inhalation in Patients with Cystic Fibrosis, Mild Lung Disease, and infection with the bacteria Pseudomonas aeruginosa (AIR-CF4)
The primary objective of this study is to assess the safety and efficacy of a 28-day course of AZLI in patients with CF, mild lung disease (FEV1 > 75% predicted), and PA.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Plus d'informations
Femme et Homme Max 99 ans
Gilead Sciences, Inc
MAJ Il y a 4 ans
Filgotinib Alone or in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have Not Yet Started Methotrexate Treatment
The primary objective of this study is to evaluate the effects of filgotinib in combination with MTX versus MTX alone for the treatment of signs and symptoms of rheumatoid arthritis (RA) as measured b...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Gilead Sciences, Inc
MAJ Il y a 4 ans
An investigational study to assess the effectiveness and safety of a new investigational drug as a add-on therapy to a Tumor Necrosis Factor Inhibitor and Methotrexate regimen in patients with moderate to severe Rheumatoid Arthritis
To assess the efficacy of GS-5745 versus placebo as an add-on therapy to a TNF inhibitor and methotrexate in subjects with moderate to severe rheumatoid arthritis Rheumatoid Arthritis.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Gilead Sciences, Inc
MAJ Il y a 4 ans
Program to Give the Drug Aztreonam Lysine for Inhalation to Patients with Cystic Fibrosis and infection by the Bacteria Pseudomonas aeruginosa Who Have Limited Treatment Options and are at Risk for Disease Progression
The primary objective of this program is to provide expanded access to aztreonam lysine for inhalation 75 mng prior to its commercial availability to patients with cystic fibrosis and chronic P. aeru...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Plus d'informations
Homme Max 99 ans
Gilead Sciences Incorporated
MAJ Il y a 4 ans
A Phase IV, Randomized, Double-Blind, Placebo-Controlled Two-Phase Crossover Study of the Metabolic Impact of Tenofovir Disoproxil Fumarate on HIV 1 Seronegative Healthy Adult Males
To assess the impact on insulin sensitivity (determined by peripheral glucose uptake using a euglycaemic clamp) of the administration of tenofovir DF compared with placebo for two weeks in HIV 1 seron...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Précédent
8
9
10
11
12
13
14
15
16
17
Suivant